Qlife Holding
1.99 SEK
-5.02 %
Less than 1K followers
QLIFE
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-5.02 %
-30.11 %
-17.29 %
-9.36 %
-48.58 %
-17.24 %
-99.78 %
-99.98 %
-99.92 %
Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.
Read moreMarket cap
31.12M SEK
Turnover
243.01K SEK
Revenue
90K
EBIT %
-61,500 %
P/E
-
Dividend yield-%
-
Coverage
Latest research
Latest analysis report
Released: 07.12.2023
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
11.2
2026
Annual report '25
26.2
2026
Extraordinary general meeting '26
13.5
2026
Interim report Q1'26
All
Research
Webcasts
Press releases
ShowingAll content types
Qlife Holding AB: Qlife submits Egoo PHE home testing system for regulatory approval
Qlife Holding AB: Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan agreements and postpones the exercise period of warrants TO7
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools